Investors Flee Drug Giants as Zantac Cancer Trials Approach
#Pharma#stock investors flee #GSK#Sanofi#Haleon as #Zantac court trials approach. Zantac was removed from the market as a probable human carcinogen, still, the studies results are not consistent